期刊文献+

利用杆状病毒载体在家蚕幼虫中高效表达人胰岛素样生长因子-2(hIGF-2) 被引量:1

Effective Expression of Human Insulin Like Growth Factor-2 in Bombyx Mori Larvae
下载PDF
导出
摘要 目的 :研制有生物活性的可溶性分泌型重组人胰岛素样生长因子 -2 (rh IGF-2 )。方法 :将 14 k Dh IGF -2前体 c DNA基因插入家蚕核型多角体病毒 (Bm NPV )转移载体 p Bak PAK8中 ,经与野生型病毒 DNA共转染家蚕细胞后 ,通过体内同源重组的方式获得重组病毒 Bm NPV/ IGF-2。以 Bm NPV/ IGF-2感染 5龄家蚕幼虫 ,分别在感染后 2 4,48,72 ,96,10 8,12 0 h提取家蚕血淋巴液 ,以 ELISA法测定不同时象家蚕血中 IGF-2浓度 ,采用 Western-blot分析鉴定 IGF -2免疫学活性 ,MTT法观察其对 NIH3 T3细胞增殖的影响。结果 :ELISA测定显示 ,Bm NPV/ IGF-2感染家蚕幼虫 96h后 IGF-2表达率最高 ,每毫升血淋巴中约含 IGF-2 14 μg,Western-blot分析发现表达产物在蚕体内被加工成 7.0 k D成熟 h IGF-2 ,并对 NIH3 T3细胞具有良好促增殖效应 ,其促细胞生长能力明显优于来源于 E.coli的 IGF-2标准品。结论 :本研究实现具有免疫学活性及生物学活性的rh AIM The purpose is to study the efficient expression and production of biologically active recombinant human insulin like growth factor 2 (rhIGF 2) in the silkworm system by the vector of Bombyx mori Nuclear Polyhedrosis Virus (BmNPV). METHODS A full length IGF 2 cDNA with the start codon was inserted into the BmNPV genome under the control of the polyhedrin promoter. Silkworm larvae (JY1) were used as hosts for the infection with recombinant BmNPV /IGF 2. rhIGF 2 concentration were detected by ELISA, and Western blot was used to find the size of IGF 2, while MTT pathway was involved to study the bioactivity of rhIGF 2 by stimulation the growth of NIH3T3 cell line. RESULTS It was found that after 48 h after infection, the concentration of IGF 2 in silkworm hemolymph could be detected(1 μg/ml),while at 72 h after infection, the level of rhIGF 2 was tested for 14.00 μg/ml). Mature rhIGF 2 with a size of 7.0 kD was identified by Western blot analysis. It was also showed that rhIGF 2 has excellent bioactivity by stimulated NIH3T3 cell growth. CONCLUSION Human IGF 2 was highly expressed by the BmNPV expression vector, and this production showed satisfied results both in bioactivity and immunol activity thus providing a very efficient way to produce soluble and biologically active mature rhIGF 2.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2002年第2期156-160,共5页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目 (课题号 39770 355)
关键词 人胰岛素样在子-2 家蚕 核型多角体病毒 基因表达 免疫学活性 生物学活性 Recombinant human insulin like growth factor 2 Gene expression Recombinant BmNPV Biological activity
  • 相关文献

参考文献3

二级参考文献12

  • 1Zhao H,Chin Med J,2001年,114卷,11期,1213页
  • 2赵红,南京医科大学学报,2000年,20卷,243页
  • 3Vorwerk P,J Clin Endoc Metab,1997年,82卷,7期,2386页
  • 41,Klinger B, Anin S, Silbergeld A, et al. Developmentof hyperandrogenism during treatment with insulin-like growth factor-Ⅰ(IGF-Ⅰ) infemale patients with Laron syndrome. Clin Endocrinol Oxf, 1998,48(1):81
  • 52,Okano K, Mikhailov VS, Mada S. Colocalization of baculovirus IE-1 and two DNA bindingproteins, DNP and LEF-3, to viral replication factories. J Virol, 1999,73(1):110
  • 63,Difalco MR, Congote LE. Preperation of a recombinant chimaera of insulin-like growthfactor Ⅱ and interleukin 3 with high proliferative potency for haemopoitic cells.Biochem J, 1997,326(Pt2):407
  • 74,Vorwerk P, Oh Y, Lee PD, et al. Synthesis of IGFBP-3 fragments in a balculovirussystem and characterization of monoclonal anti-IGFBP-3 antibodies. J Clin EndocrinolMetab, 1997,82(7):2368
  • 85,Summers ND, Smith GE. A manual of methods for balculovirus insect cells cultureprocedures. Taxas Agricultural Experimental Station Bulletin, College Station,Tex.1987,No. 1555
  • 96,Bovenberg WA, Dauwerse JG, Pospiech HM, et al. Expression of recombinant humaninsulin-like growth factor Ⅰ in mammalian cells. Molecular and Cellular Endocrinology,1990,74:45
  • 107,Clemmons DR. Usefulness of insulin like growth factors and their binding proteins inthe diagnosis of disease. Current Opinion in Endocrinology and Diabetes, 1997,4:26 (1999-12-10收稿)

共引文献17

同被引文献8

  • 1Koziel MJ, Dudley D, Afdhal N, et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV [J]. J Virol, 1993; 67:7522-7532.
  • 2Summers MD, Smith GE. A manual of method for baculovirus vector and insect cell culture procedures [J]. Texas Agricultur Experi Station Texas A&M Univ, 1987;27-30.
  • 3Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus putative envelope glycoprotein varant: Potential role in chronic HCV infections [J]. Proc Natl Aca Sci USA, 1992; 89: 3468-3472.
  • 4Taniguchi S, Okamoto H, Sakamoto M, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 proteion: Implication for an escape from antibody [J]. Virology, 1993; 195: 297-301.
  • 5Shimizu YK, Igarashi H, Kiyohara T, et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervarivable region 1 of hepatitis C virus can prevent viral infection in cell cultures [J]. Virology, 1996; 233: 409-412.
  • 6Zibert A, Dudziak P, Schreier E, et al. Characterizatio of antibody response th hepatitis C virus proteion E2 and significance of hyper variable region 1-specific antibodies in viral neutralization [J]. Arch Virol, 1997; 142: 523-534.
  • 7Duenas-Carrera S, Vina A, Martinez R, et al. Immunization with a DNA vaccine encoding the hepatitis C virus structural antigens elicits specific immune response against the capsid and envelope proteins in rabbits and macaquesirus [J]. Biotechnol Appl Biochem, 2004;39:249-255.
  • 8赵平,张珉,曹洁,王宏卫,戚中田.口服型HCV融合抗原DNA疫苗在小鼠诱导免疫应答[J].中国生物化学与分子生物学报,2003,19(4):509-512. 被引量:2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部